Association of Adjuvant Chemotherapy With Overall Survival in Patients With Early-Stage Breast Cancer and 21-Gene Recurrence Scores of 26 or Higher

This cohort study investigates the association of overall survival with receiving chemotherapy among patients with early-stage breast cancer and recurrence scores of 26 to 30 vs those with recurrence scores of 31 or greater.

Detalles Bibliográficos
Autores principales: Ma, Sung Jun, Oladeru, Oluwadamilola T., Singh, Anurag K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199111/
https://www.ncbi.nlm.nih.gov/pubmed/32364592
http://dx.doi.org/10.1001/jamanetworkopen.2020.3876
_version_ 1783529099301486592
author Ma, Sung Jun
Oladeru, Oluwadamilola T.
Singh, Anurag K.
author_facet Ma, Sung Jun
Oladeru, Oluwadamilola T.
Singh, Anurag K.
author_sort Ma, Sung Jun
collection PubMed
description This cohort study investigates the association of overall survival with receiving chemotherapy among patients with early-stage breast cancer and recurrence scores of 26 to 30 vs those with recurrence scores of 31 or greater.
format Online
Article
Text
id pubmed-7199111
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-71991112020-05-06 Association of Adjuvant Chemotherapy With Overall Survival in Patients With Early-Stage Breast Cancer and 21-Gene Recurrence Scores of 26 or Higher Ma, Sung Jun Oladeru, Oluwadamilola T. Singh, Anurag K. JAMA Netw Open Research Letter This cohort study investigates the association of overall survival with receiving chemotherapy among patients with early-stage breast cancer and recurrence scores of 26 to 30 vs those with recurrence scores of 31 or greater. American Medical Association 2020-05-04 /pmc/articles/PMC7199111/ /pubmed/32364592 http://dx.doi.org/10.1001/jamanetworkopen.2020.3876 Text en Copyright 2020 Ma SJ et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Ma, Sung Jun
Oladeru, Oluwadamilola T.
Singh, Anurag K.
Association of Adjuvant Chemotherapy With Overall Survival in Patients With Early-Stage Breast Cancer and 21-Gene Recurrence Scores of 26 or Higher
title Association of Adjuvant Chemotherapy With Overall Survival in Patients With Early-Stage Breast Cancer and 21-Gene Recurrence Scores of 26 or Higher
title_full Association of Adjuvant Chemotherapy With Overall Survival in Patients With Early-Stage Breast Cancer and 21-Gene Recurrence Scores of 26 or Higher
title_fullStr Association of Adjuvant Chemotherapy With Overall Survival in Patients With Early-Stage Breast Cancer and 21-Gene Recurrence Scores of 26 or Higher
title_full_unstemmed Association of Adjuvant Chemotherapy With Overall Survival in Patients With Early-Stage Breast Cancer and 21-Gene Recurrence Scores of 26 or Higher
title_short Association of Adjuvant Chemotherapy With Overall Survival in Patients With Early-Stage Breast Cancer and 21-Gene Recurrence Scores of 26 or Higher
title_sort association of adjuvant chemotherapy with overall survival in patients with early-stage breast cancer and 21-gene recurrence scores of 26 or higher
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199111/
https://www.ncbi.nlm.nih.gov/pubmed/32364592
http://dx.doi.org/10.1001/jamanetworkopen.2020.3876
work_keys_str_mv AT masungjun associationofadjuvantchemotherapywithoverallsurvivalinpatientswithearlystagebreastcancerand21generecurrencescoresof26orhigher
AT oladeruoluwadamilolat associationofadjuvantchemotherapywithoverallsurvivalinpatientswithearlystagebreastcancerand21generecurrencescoresof26orhigher
AT singhanuragk associationofadjuvantchemotherapywithoverallsurvivalinpatientswithearlystagebreastcancerand21generecurrencescoresof26orhigher

Ejemplares similares